As part of our new biomedion rebranding strategy, the product name will change from arivis5D to neuronOS. The new brand reinforces the company’s GxP quality, compliance and archiving divisions and enhances the opportunity to grow as an enterprise platform for all types of digital content including images and remains unique in the marketplace.
The name change to neuronOS also reflects our strategy targeted to emphasize collaboration and distributed architectures as a de-facto operating system to leverage innovation along the whole life sciences lifecycle.
biomedion is relaunching neuronos: A Solution for the Pharma Quality
Nov 29, 2021 8:34:16 AM
You may also like
Is there a solution to the current data capture gap?
Is there a solution to the current data capture gap?
2 January, 2023Research data capture and cleaning is critical for R&D teams, but it can be time-consuming and prone to errors. The ...
Changes Ahead: Prepare for New FDA Guidance on Annual IND Reporting
Changes Ahead: Prepare for New FDA Guidance on Annual IND Reporting
27 April, 2023Are you ready for the IND (Investigational New Drug) annual reporting major changes? The FDA (Food and Drug Administrati...
The Future of AI in Health Sciences and the Challenges of Long Term Archiving
The Future of AI in Health Sciences and the Challenges of Long Term Archiving
12 September, 2024Overcoming Long-term Archiving Challenges The intersection of artificial intelligence (AI) and healthcare is quickly cha...